Background A 55-year-old male was diagnosed with poorly differentiated thyroid cancer after total thyroidectomy, which was performed because of progressive enlargement of a dominant thyroid nodule.

Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC): Results of a multicenter phase II international ...

An oncology nurse treated her patients throughout the worst days of the pandemic—but a golf ball–size lump was a clue to her ...

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new ...

Most thyroid cancers are differentiated cancers. The cells in these cancers look a lot like normal thyroid cells when seen in the lab. These cancers develop from thyroid follicular cells. Papillary ...

European Society Medical Oncology (ESMO): Thyroid cancer, Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. 2019. National Institute for Health and Care Excellence (NICE). TA535: ...

Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that ...

Despite multimodality treatment for thyroid cancer, including surgical resection, radioiodine therapy, thyrotropin (TSH)-suppressive thyroxine treatment, and ...

Aim: To compare the new, 6th edition, UICC TNM staging system with the former edition, we updated TNM staging in patients with differentiated thyroid carcinoma. Methods: The new and old TNM ...

Are Needs Assessments Cost Effective in Reducing Distress Among Patients With Cancer? A Randomized Controlled Trial Using the Distress Thermometer and Problem List We conducted a double-blind, phase ...